> The drug in question, Aduhelm, was approved by the agency last month and has caused an uproar in the scientific community. Three of the agency's scientific advisors resigned following the decision.
Is this sort of thing common? Seems like an investigation is definitely warranted if this type of resignation is a rare as I would imagine it be.
Is this sort of thing common? Seems like an investigation is definitely warranted if this type of resignation is a rare as I would imagine it be.